No retraction, correction or concern found when last checked on Oct 20, 2026.

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2

Francesca Salamanna, Melania Maglio, Maria Paola Landini and 1 more

Frontiers in Medicine · 2020 · Review · CC BY

doi:10.3389/fmed.2020.594495

Abstract

The explosion of the new coronavirus (SARS-CoV-2) pandemic has brought the role of the angiotensin converting enzyme 2 (ACE2) back into the scientific limelight. Since SARS-CoV-2 must bind the ACE2 for entering the host cells in humans, its expression and body localization are critical to track the potential target organ of this infection and to outline disease progression and clinical outcomes. Here, we mapped the physiological body distribution, expression, and activities of ACE2 and discussed its potential correlations and mutal interactions with the disparate symptoms present in SARS-CoV-2 patients at the level of different organs. We highlighted that despite during SARS-CoV-2 infection ACE2-expressing organs may become direct targets, leading to severe pathological manifestations, and subsequent multiple organ failures, the exact mechanism and the potential interactions through which ACE2 acts in these organs is still heavily debated. Further scientific efforts, also considering a personalized approach aimed to consider specific patient differences in the mutual interactions ACE2-SARS-CoV-2 and the long-term health effects associated with COVID-19 are currently mandatory.

References 341

1.
Huang C Wang Y Li X Ren L Zhao J Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020 ) 395:497–506.
Not in our library10.1016/s0140-6736(20)30183-5
2.
Chen N Zhou M Dong X Qu J Gong F Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. (2020 ) 395:507–13.
Not in our library10.1016/s0140-6736(20)30211-7
3.
Mukherjee R Smith A Sutton R. Covid-19-related pancreatic injury. Br J Surg. (2020 ) 107:e190.
Not in our library10.1002/bjs.11645
4.
Lin L Jiang X Zhang Z Huang S Zhang Z Fang Z. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. (2020 ) 69:997–1001.
Not in our library10.1136/gutjnl-2020-321013
5.
de-Madaria E Siau K Cárdenas-Jaén K. Increased amylase and lipase in patients with COVID-19 pneumonia: don't blame the pancreas just yet! Gastroenterology. (2020 ).. [Epub ahead of print].
Not in our library10.1053/j.gastro.2020.04.044
6.
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China · 2020
No notice
7.
Wu Y Xu X Chen Z Duan J Hashimoto K Yang L. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. (2020 ) 87:18–22.
Not in our library10.1016/j.bbi.2020.03.031
8.
Akhmerov A Marban E. COVID-19 and the heart. Circ Res. (2020 ) 126:1443–55.
Not in our library10.1161/circresaha.120.317055
9.
Terpos E Ntanasis-Stathopoulos I Elalamy I Kastritis E Sergentanis TN Politou M. Hematological findings and complications of COVID-19. Am J Hematol. (2020 ) 95:834–47.
Not in our library10.1002/ajh.25829
10.
Loffredo L Pacella F Pacella E Tiscione G Oliva A Violi F. Conjunctivitis and COVID-19: a meta-analysis. J Med Virol. (2020 ).. [Epub ahead of print].
Not in our library10.1002/jmv.25938
11.
Vaira LA Salzano G Fois AG Piombino P De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. (2020 ) 10:1103–4.
Not in our library10.1002/alr.22593
12.
Rothan HA Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. (2020 ) 109:102433.
Not in our library10.1016/j.jaut.2020.102433
13.
Madjid M Safavi-Naeini P Solomon SD Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. (2020 ) 5:831–40.
Not in our library10.1001/jamacardio.2020.1286
14.
Guan WJ Liang WH Zhao Y Liang HR Chen ZS Li YM. China medical treatment expert group for COVID-19. comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J. (2020 ) 55:2000547.
Not in our library10.1183/13993003.00547-2020
15.
Crackower MA Sarao R Oudit GY Yagil C Kozieradzki I Scanga SE. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. (2020 ) 417:822–8.
Not in our library10.1038/nature00786
16.
Hoffmann M Kleine-Weber H Schroeder S Krüger N Herrler T Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020 ) 181:271–80.e8.
Not in our library10.1016/j.cell.2020.02.052
17.
Turner AJ Hiscox JA Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. (2004 ) 25:291–4.
Not in our library10.1016/j.tips.2004.04.001
18.
Walls AC Park YJ Tortorici MA Wall A McGuire AT Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. (2020 ) 181:281–92.e6.
Not in our library10.1016/j.cell.2020.02.058
19.
Glowacka I Bertram S Müller MA Allen P Soilleux E Pfefferle S. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. (2011 ) 85:4122–34.
Not in our library10.1128/jvi.02232-10
20.
Wrapp D Wang N Corbett KS Goldsmith JA Hsieh CL Abiona O. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. (2020 ) 367:1260–63.
Not in our library10.1126/science.abb2507
21.
Coutard B Valle C de Lamballerie X Canard B Seidah NG Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. (2020 ) 176:104742.
Not in our library10.1016/j.antiviral.2020.104742
22.
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells · 2020
No notice
23.
Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2) · 2005
No notice
24.
Heurich A Hofmann-Winkler H Gierer S Liepold T Jahn O Pöhlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. (2014 ) 88:1293–307.
Not in our library10.1128/jvi.02202-13
25.
Tipnis SR Hooper NM Hyde R Karran E Christie G Turner AJ. A human homolog of angiotensinconverting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. (2000 ) 275:33238–43.
Not in our library10.1074/jbc.m002615200
26.
Komukai K Mochizuki S Yoshimura M. Gender and the renin-angiotensin-aldosterone system. Fundam Clin Pharmacol. (2010 ) 24:687–98.
Not in our library10.1111/j.1472-8206.2010.00854.x
27.
World Health Organization Coronavirus Disease (COVID-19) Outbreak. WHO (2020 ). Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Not in our library
28.
Hamming I Timens W Bulthuis ML Lely AT Navis G van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. a first step in understanding SARS pathogenesis. J Pathol. (2004 ) 203:631–7.
Not in our library10.1002/path.1570
29.
Harmer D Gilbert M Borman R Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. (2002 ) 532:107–10.
Not in our library10.1016/s0014-5793(02)03640-2
30.
Trojanowicz B Ulrich C Kohler F Bode V Seibert E Fiedler R. Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease. Nephrol Dial Transplant. (2017 ) 32:287–98.
Not in our library10.1093/ndt/gfw206
31.
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa · 2020
No notice
32.
Uhlén M Fagerberg L Hallström BM. Proteomics. Tissue-based map of the human proteome. Science. (2015 ) 347:1260419.
Not in our library10.1126/science.1260419
33.
Cole-Jeffrey CT Liu M Katovich MJ Raizada MK Shenoy V. ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy. J Cardiovasc Pharmacol. (2015 ) 66:540–50.
Not in our library10.1097/fjc.0000000000000307
34.
Vargas F Rodríguez-Gómez I Vargas-Tendero P Jimenez E Montiel M. The renin-angiotensin system in thyroid disorders and its role in cardiovascular and renal manifestations. J Endocrinol. (2012 ) 213:25–36.
Not in our library10.1530/joe-11-0349
35.
Diniz GP Senger N Carneiro-Ramos MS Santos RA Barreto-Chaves ML. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Ther Adv Cardiovasc Dis. (2016 ) 10:192–202.
Not in our library10.1177/1753944715623228
36.
Narayan SS Lorenz K Ukkat J Hoang-Vu C Trojanowicz B. Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression. Neoplasma. (2020 ) 67:402–9.
Not in our library10.4149/neo_2019_190506n405
37.
Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy. · 2012
Not checked
38.
Alenina N Bader M. ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models. Neurochem Res. (2019 ) 44:1323–9.
Not in our library10.1007/s11064-018-2679-4
39.
Wang XL Iwanami J Min LJ Tsukuda K Nakaoka H Bai HY. Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function. NPJ Aging Mech Dis. (2016 ) 2:16024.
Not in our library10.1038/npjamd.2016.24
40.
Klempin F Mosienko V Matthes S Villela DC Todiras M Penninger JM. Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response. Cell Mol Life Sci. (2018 ) 75:3625–34.
Not in our library10.1007/s00018-018-2815-y
41.
Hashimoto T Sakata Y Fukushima K Maeda T Arita Y Shioyama W. Pulmonary arterial hypertension associated with chronic active Epstein-Barr virus infection. Intern Med. (2011 ) 50:119–24.
Not in our library10.2169/internalmedicine.50.4143
42.
Singer D Camargo SM. Collectrin and ACE2 in renal and intestinal amino acid transport. Channels. (2011 ) 5:410–23.
Not in our library10.4161/chan.5.5.16470
43.
Hashimoto T Perlot T Rehman A Trichereau J Ishiguro H Paolino M. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. (2012 ) 487:477–81.
Not in our library10.1038/nature11228
44.
Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease · 2012
No notice
45.
Batlle D Jose Soler M Ye M. ACE2 and diabetes: ACE of ACEs? Diabetes. (2010 ) 59:2994–6.
Not in our library10.2337/db10-1205
46.
Bindom SM Lazartigues E The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. (2009 ) 302:193–202.
Not in our library10.1016/j.mce.2008.09.020
47.
Xuan X Gao F Ma X Huang C Wang Y Deng H. Activation of ACE2/angiotensin (1-7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model. Metabolism. (2018 ) 81:83–96.
Not in our library10.1016/j.metabol.2017.12.003
48.
Kuba K Imai Y Ohto-Nakanishi T Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. (2010 ) 128:119–28.
Not in our library10.1016/j.pharmthera.2010.06.003
49.
Herath CB Warner FJ Lubel JS Dean RG Jia Z Lew RA. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol. (2007 ) 47:387–95.
Not in our library10.1016/j.jhep.2007.03.008
50.
Pirola CJ Sookoian S. SARS-CoV-2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID-19. Liver Int. (2020 ) 40:2038–40.
Not in our library10.1111/liv.14500
51.
Holappa M Valjakka J Vaajanen A. Angiotensin(1-7) and ACE2, “The Hot Spots” of renin-angiotensin system, detected in the human aqueous humor. Open Ophthalmol J. (2015 ) 9:28–32.
Not in our library10.2174/1874364101509010028
52.
Holappa M Vapaatalo H Vaajanen A. Many faces of renin-angiotensin system - focus on eye. Open Ophthalmol J. (2017 ) 11:122–42.
Not in our library10.2174/1874364101711010122
53.
Lange C Wolf J Auw-Haedrich C Schlecht A Boneva S Lapp T. Expression of the COVID-19 receptor ACE2 in the human conjunctiva. J Med Virol. (2020 ).. [Epub ahead of print].
Not in our library10.1002/jmv.25981
54.
Ma D Chen CB Jhanji V Xu C Yuan XL Liang JJ. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye. (2020 ) 34:1212–9.
Not in our library10.1038/s41433-020-0939-4
55.
Sims AC Baric RS Yount B Burkett SE Collins PL Pickles RJ. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol. (2005 ) 79:15511–24.
Not in our library10.1128/jvi.79.24.15511-15524.2005
56.
Sun K Gu L Ma L Duan Y Atlas of ACE2 gene expression in mammals reveals novel insights in transmission of SARS-Cov-2. BioRxiv. (2020 ).
Not in our library10.1101/2020.03.30.015644
57.
Liao X Xiao J Li SH Xiao LL Cheng B Fu XB. Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells. Biochim Biophys Acta Mol Basis Dis. (2019 ) 1865:2647–56.
Not in our library10.1016/j.bbadis.2019.07.006
58.
Grzegrzolka J Swiatko K Pula B Zamirska A Olbromski M Bieniek A. ACE and ACE2 expression in normal and malignant skin lesions. Folia Histochem Cytobiol. (2013 ) 51:232–8.
Not in our library10.5603/fhc.2013.0033
59.
Delforce SJ Lumbers ER Corbisier de Meaultsart C Wang Y Proietto A Otton G. Expression of renin-angiotensin system (RAS) components in endometrial cancer. Endocr Connect. (2017 ) 6:9–19.
Not in our library10.1530/ec-16-0082
60.
Jing Y Run-Qian L Hao-Ran W Hao-Ran C Ya-Bin L Yang G. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. (2020 ) 26:367–73.
Not in our library10.1093/molehr/gaaa030
61.
scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells · 2020
No notice
62.
Hickman PJ Filipeanu CM Wu G Lazartigues E. Angiotensin converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation. Circ Res. (2008 ) 102:729–36.
Not in our library10.1161/circresaha.107.169110
63.
Haznedaroglu IC Malkan UY. Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies. Eur Rev Med Pharmacol Sci. (2016 ) 20:4089–111.
Not in our library
64.
El-Anwar MW Elzayat S Fouad YA. ENT manifestation in COVID-19 patients. Auris Nasus Larynx. (2020 ) 47:559–64.
Not in our library10.1016/j.anl.2020.06.003
65.
COVID-19 in otolaryngologist practice: a review of current knowledge · 2020
No notice
66.
Lechien JR Chiesa-Estomba CM De Siati DR Horoi M Le Bon SD Rodriguez A. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. (2020 ) 277:2251–61.
Not in our library10.1007/s00405-020-05965-1
67.
Giacomelli A Pezzati L Conti F Bernacchia D Siano M Oreni L. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. (2020 ) 71:889–90.
Not in our library10.1093/cid/ciaa330
68.
Moein ST Hashemian SM Mansourafshar B Khorram-Tousi A Tabarsi P Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. (2020 ) 10:944–50.
Not in our library10.1002/alr.22587
69.
Lechien J Cabaraux P Chiesa-Estomba C Khalife M Plzak J Hans S Objective olfactory testing in patients presenting with sudden onset olfactory dysfunction as the first manifestation of confirmed COVID-19 infection. Endocr Connect. (2017 ) 6:9–19. 27956412
Not in our library10.1101/2020.04.15.20066472
70.
Kaye R Chang CWD Kazahaya K Brereton J Denneny JC III. COVID-19 anosmia reporting tool: initial findings. Otolaryngol Head Neck Surg. (2020 ) 163:132–4.
Not in our library10.1177/0194599820922992
71.
Hopkins C Surda P Kumar N Presentation of new onset anosmia during the COVID19 pandemic. Rhinology. (2020 ) 58:295–8.
Not in our library10.4193/rhin20.116
72.
Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations · 2020
No notice
73.
Lechien JR Chiesa-Estomba CM Place S Van Laethem Y Cabaraux P Mat Q. Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. (2020 ) 288:335–44.
Not in our library10.1111/joim.13089
74.
Muus C Luecken MD Eraslan G Waghray A Heimberg G Sikkema Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells. bioRxiv. (2020 ).
Not in our library10.1101/2020.04.19.049254
75.
Lechner M Chandrasekharan D Jumani K Liu J Gane S Lund VJ. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - a systematic review of the literature, case series, and recommendations for clinical assessment and management. Rhinology. (2020 ) 58:394–9.
Not in our library10.4193/rhin20.189
76.
Olender T Keydar I Pinto JM Tatarskyy P Alkelai A Chien MS. The human olfactory transcriptome. BMC Genomics. (2016 ) 17:619.
Not in our library10.1186/s12864-016-2960-3
77.
Galougahi MK Ghorbani J Bakhshayeshkaram M Naeini AS Haseli S. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: the first report. Acad Radiol. (2020 ) 27:892–3.
Not in our library10.1016/j.acra.2020.04.002
78.
Eliezer M Hautefort C Hamel AL Verillaud B Herman P Houdart E. Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. (2020 ) 146:674–5.
Not in our library10.1001/jamaoto.2020.0832
79.
Butowt R Bilinska K. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem Neurosci. (2020 ) 11:1200–3.
Not in our library10.1021/acschemneuro.0c00172
80.
Brann DH Tsukahara T Weinreb C Lipovsek M Van den Berge K Gong B. Nonneuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19- associated anosmia. bioRxiv. (2020 ) 6:eabc5801.
Not in our library10.1101/2020.03.25.009084
81.
Fodoulian L Tuberosa J Rossier D Landis BN Carleton A Rodriguez I SARS-CoV-2 receptor and entry genes are expressed by sustenacular cells in the human olfactory neuroepithelium. bioRxiv. (2020 ).
Not in our library10.1101/2020.03.31.013268
82.
Qi J Zhou Y Hua J Zhang L Bian J Liu B The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. bioRxiv. (2020 ).
Not in our library10.1101/2020.04.16.045690
83.
Sabino Silva R Jardim ACG Siqueira WL. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin Oral Invest. (2020 ) 24:1619–21.
Not in our library10.1007/s00784-020-03248-x
84.
To KK Tsang OT Yip CC Chan KH Wu TC Chan JM. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. (2020 ) 71:841–3.
Not in our library10.1093/cid/ciaa149
85.
Chen L Zhao J Peng J Li X Deng X Geng Z Detection of 2019-nCoV in Saliva and Characterization of Oral Symptoms in COVID-19 Patients. (2020 ). Available online at: https://ssrn.com/abstract=3557140 (accessed August 10, 2020)
Not in our library
86.
van Riel D Verdijk R Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol. (2015 ) 235:277–87.
Not in our library10.1002/path.4461
87.
Vinayachandrana D Balasubramanianb S. Salivary diagnostics in COVID-19: Future research implications. J Dent Sci. (2020 ) 15:364–6.
Not in our library10.1016/j.jds.2020.04.006
88.
Brandão TB Gueiros LA Melo TS Prado-Ribeiro AC Nesrallah ACFA Prado GVB. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol. (2020 ) 18:S2212-4403(20)31119-6.
Not in our library10.1016/j.oooo.2020.07.014
89.
Cruz Tapia RO Peraza Labrador AJ Guimaraes DM Matos Valdez LH. Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. are they a true sign of COVID-19 disease? Spec Care Dentist. (2020 ) 40:555–60.
Not in our library10.1111/scd.12520
90.
Hummel T Landis BN Hüttenbrink KB Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg. (2011 ) 10:Doc04
Not in our library10.3205/cto000077
91.
Mariz BALA Brandão TB Ribeiro ACP Lopes MA Santos-Silva AR. New insights for the pathogenesis of COVID-19-related dysgeusia. J Dent Res. (2020 ) 99:1206.
Not in our library10.1177/0022034520936638
92.
Xia J Tong J Liu M Shen Y Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. (2020 ) 92:589–94.
Not in our library10.1002/jmv.25725
93.
Shemer A Einan-Lifshitz A Itah A Dubinsky-Pertzov B Pras E Hecht I. Ocular involvement in coronavirus disease 2019 (COVID-19): a clinical and molecular analysis. Int Ophthalmol. (2020 ) 1–8.
Not in our library10.1007/s10792-020-01592-1
94.
Lee YH Kim YC Shin JP. Characteristics of ocular manifestations of patients with coronavirus disease 2019 in Daegu Province, Korea. J Korean Med Sci. (2020 ) 35:e322.
Not in our library10.3346/jkms.2020.35.e322
95.
Pérez-Bartolomé F Sánchez-Quirós J. Ocular manifestations of SARS-CoV-2: literature review. Arch Soc Esp Oftalmol. (2020 ).. [Epub ahead of print].
Not in our library10.1016/j.oftal.2020.07.020
96.
Guan WJ Ni ZY Hu Y Liang WH Ou CQ He JX Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. (2020 ) 382:1708–20.
Not in our library10.1056/nejmoa2002032
97.
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China · 2020
No notice
98.
Seah IYJ Anderson DE Kang AEZ Wang L Rao P Young BE. Assessing viral shedding and infectivity of tears in Coronavirus disease 2019 (COVID-19) patients. Ophthalmology. (2020 ) 127:977–9.
Not in our library10.1016/j.ophtha.2020.03.026
99.
Hoenig LJ. The eye and COVID-19 pandemic. Clin Dermatol. (2020 ) 38:506.
Not in our library10.1016/j.clindermatol.2020.03.013
100.
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study · 2020
Not checked
101.
Casagrande M Fitzek A Püschel K Aleshcheva G Schultheiss HP Berneking L. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. (2020 ) 28:721–5.
Not in our library10.1080/09273948.2020.1770301
102.
Chen L Liu M Zhang Z Qiao K Huang T Chen M. Ocular manifestations of a hospitalized patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. (2020 ) 104:748–51.
Not in our library10.1136/bjophthalmol-2020-316304
103.
Xia J Tong J Liu M Shen Y Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. (2020 ) 92:589–94.
Not in our library10.1002/jmv.25725
104.
Li S Li D Fang J Liu Q Cao W Sun X. SARS-CoV-2 receptor ACE2 is expressed in human conjunctival tissue, especially in diseased conjunctival tissue. Ocul Surf. (2020 ).. [Epub ahead of print].
Not in our library10.1016/j.jtos.2020.09.010
105.
Goel R Arora R Chhabra M Kumar S. Viral shedding in tears of COVID-19 cases presenting as conjunctivitis. Indian J Ophthalmol. (2020 ) 68:2308.
Not in our library10.4103/ijo.ijo_2567_20
106.
Xie H Jiang S Xu K Liu X Xu B Wang L. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis. (2020 ) 7:23.
Not in our library10.1186/s40662-020-00189-0
107.
Loon SC Teoh SC Oon LL Se-Thoe SY Ling AE Leo YS. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. (2004 ) 88:861–3.
Not in our library10.1136/bjo.2003.035931
108.
Li JO Lam D Chen Y Ting D. Novel coronavirus disease 2019 (COVID-19): the importance of recognizing possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. (2020 ) 104:297–8.
Not in our library10.1136/bjophthalmol-2020-315994
109.
Qing H Li Z Yang Z Shi M Huang Z Song J. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol. (2020 ) 98:e388.
Not in our library10.1111/aos.14412
110.
Zhe L Chuan-Bin S. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract. J Med Virol. (2020 ).. [Epub ahead of print].
Not in our library10.1002/jmv.25859
111.
Sun Y Liu L Pan X Jing M Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int J Ophthalmol. (2006 ) 6:783–6.
Not in our library
112.
Sungnak W Huang N Bécavin C Berg M Queen R Litvinukova M. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. (2020 ) 26:681–7.
Not in our library10.1038/s41591-020-0868-6
113.
Li YC Bai WZ Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. (2020 ) 92:552–5.
Not in our library10.1002/jmv.25728
114.
Seah I Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? a review of coronaviruses and ocular implications in humans and animals. Ocular Immunol Inflamm. (2020 ) 28:391–5.
Not in our library10.1080/09273948.2020.1738501
115.
Yang X Yu Y Xu J Shu H Xia J Liu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. (2020 ) 8:475–81.
Not in our library10.1016/s2213-2600(20)30079-5
116.
Xu Z Shi L Wang Y Zhang J Huang L Zhang C Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. (2020 ) 8:420–2.
Not in our library10.1016/s2213-2600(20)30076-x
117.
Kanne JP. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. (2020 ) 295:16–7.
Not in our library10.1148/radiol.2020200241
118.
Chung M Bernheim A Mei X Zhang N Huang M Zeng X. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. (2020 ) 295:202–7.
Not in our library10.1148/radiol.2020200230
119.
Lei J Li J Li X Qi X CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. (2020 ) 295:18
Not in our library10.1148/radiol.2020200236
120.
Pan Y Guan H Zhou S Wang Y Li Q Zhu T. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol. (2020 ) 30:3306–9.
Not in our library10.1007/s00330-020-06731-x
121.
Bai HX Hsieh B Xiong Z Halsey K Choi JW Tran TML Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. (2020 ) 296:E46–54.
Not in our library10.1148/radiol.2020200823
122.
Rodriguez-Morales AJ Cardona-Ospina JA Gutiérrez-Ocampo E Villamizar-Peña R Holguin-Rivera Y Escalera-Antezana JP. Latin American network of coronavirus disease 2019-COVID-19 research (LANCOVID-19). Travel Med Infect Dis. (2020 ) 34:101623.
Not in our library10.1016/j.tmaid.2020.101623
123.
Xie X Zhong Z Zhao W Zheng C Wang F Liu J. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology. (2020 ) 296:E41–5.
Not in our library10.1148/radiol.2020200343
124.
Zhu H Wang L Fang C Peng S Zhang L Chang G. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Ped. (2020 ) 9:51–60.
Not in our library10.21037/tp.2020.02.06
125.
Wei J Xu H Xiong J Shen Q Fan B Ye C. 2019 Novel coronavirus (COVID-19) pneumonia: serial computed tomography findings. Korean J Radiol. (2020 ) 21:501–4.
Not in our library10.3348/kjr.2020.0112
126.
Song F Shi N Shan F Zhang Z Shen J Lu H. Emerging 2019 novel coronavirus 2019-nCoV) pneumonia. Radiology. (2020 ) 295:210–17.
Not in our library10.1148/radiol.2020200274
127.
Lee KS. Pneumonia associated with 2019 novel coronavirus: can computed tomographic findings help predict the prognosis of the disease? Korean J Radiol. (2020 ) 21:257–8.
Not in our library10.3348/kjr.2020.0096
128.
Vaseghi G Mansourian M Karimi R Heshmat-Ghahdarijani K Baradaran Mahdavi S Clinical characterization and chest CT findings in laboratory-confirmed COVID-19: a systematic review and meta-analysis. medRxiv. (2020 ).
Not in our library10.1101/2020.03.05.20031518
129.
Zhao W Zhong Z Xie X Yu Q Liu J. Relation Between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. Am J Roentgenol. (2020 ) 214:1072–7.
Not in our library10.2214/ajr.20.22976
130.
Diao K Han P Pang T Li Y Yang Z HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia. Prec Clin Med. (2020 ) 3:9–13.
Not in our library10.1093/pcmedi/pbaa004
131.
Fang Y Zhang H Xu Y Xie J Pang P Ji W. CT manifestations of two cases of 2019 novel coronavirus (2019- nCoV) pneumonia. Radiology. (2020 ) 295:208–9.
Not in our library10.1148/radiol.2020200280
132.
Xie Y Yang L Dong H Peng H Yu Y CT Scores Predict Mortality in 2019-nCoV Pneumonia. Clinical Trial registered. NCT04284046. NIH (2020 ).
Not in our library
133.
Kong W Agarwal PP Chest imaging appearance of COVID-19 infection. Radiol Cardiothor Imaging. (2020 ) 2:e200028
Not in our library10.1148/ryct.2020200028
134.
Bernheim A Mei X Huang M Yang Y Fayad ZA Zhang N. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. (2020 ) 295:200463.
Not in our library10.1148/radiol.2020200463
135.
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction · 2020
No notice
136.
Barisione E Grillo F Ball L Bianchi R Grosso M Morbini P. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. (2020 ) 1–15.
Not in our library10.1007/s00428-020-02934-1
137.
Angiotensin‐converting enzyme 2 ( ACE2 ), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 ( COVID ‐19) · 2020
No notice
138.
Kuba K Imai Y Rao S Gao H Guo F Guan B. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. (2005 ) 11:875–9.
Not in our library10.1038/nm1267
139.
Imai Y Kuba K Rao S Huan Y Guo F Guan B. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. (2005 ) 436:112–16.
Not in our library10.1038/nature03712
140.
Hung YH Hsieh WY Hsieh JS Liu FC Tsai CH Lu LC. Alternative roles of STAT3 and MAPK signaling pathways in the MMPs activation and progression of lung injury induced by cigarette smoke exposure in ACE2 knockout Mice. Int J Biol Sci. (2016 ) 12:454–65.
Not in our library10.7150/ijbs.13379
141.
Lin CI Tsai CH Sun YL Hsieh WY Lin YC Chen CY. Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE2 knockout mice. Int J Biol Sci. (2018 ) 14:253–65.
Not in our library10.7150/ijbs.23489
142.
Barkauskas CE Cronce MJ Rackley CR Bowie EJ Keene DR Stripp BR. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. (2013 ) 123:3025–36.
Not in our library10.1172/jci68782
143.
Rivellese F Prediletto E. ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia. Autoimmun Rev. (2020 ) 19:102536.
Not in our library10.1016/j.autrev.2020.102536
144.
Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts · 2012
No notice
145.
Sato T Ueha R Goto T Yamauchi A Kondo K Yamasoba T. Expression of ACE2 and TMPRSS2 proteins in the upper and lower aerodigestive tracts of rats. biorxiv. (2020 ).
Not in our library10.1101/2020.05.14.097204
146.
Wong HYF Lam HYS Fong AH Leung ST Chin TW Lo CSY. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology. (2020 ) 296:E72–8.
Not in our library10.1148/radiol.2020201160
147.
Mehta P McAuley DF Brown M Sanchez E Tattersall RS Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. (2020 ) 395:1033–4.
Not in our library10.1016/s0140-6736(20)30628-0
148.
Topol EJ. COVID-19 can affect the heart. Science. (2020 ) 370:408–9.
Not in our library10.1126/science.abe2813
149.
Ruan Q Yang K Wang W Jiang L Song J Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. (2020 ) 46:846–8.
Not in our library10.1007/s00134-020-05991-x
150.
Wang D Hu B Hu C Zhu F Liu X Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. (2020 ) 323:1061–9.
Not in our library10.1001/jama.2020.1585
151.
Liu K Fang YY Deng Y Liu W Wang MF Ma JP Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J. (2020 ) 133:1025–31.
Not in our library10.1097/cm9.0000000000000744
152.
Zhou F Yu T Du R Fan G Liu Y Liu Z Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020 ) 395:1054–62.
Not in our library10.1016/s0140-6736(20)30566-3
153.
Hu H Ma F Wei X Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. (2020 ) ehaa190.
Not in our library10.1093/eurheartj/ehaa190
154.
Zeng JH Liu YX Yuan J Wang FX Wu WB Li JX. First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection. (2020 ) 48:773–7.
Not in our library10.1007/s15010-020-01424-5
155.
Li XC Zhang J Zhuo JL. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. (2017 ) 125:21–38.
Not in our library10.1016/j.phrs.2017.06.005
156.
Breidenbach JD Dube P Ghosh S Abdullah BN Modyanov NN Malhotra D. Impact of comorbidities on SARS-CoV-2 viral entry-related genes. J Pers Med. (2020 ) 10:e146.
Not in our library10.3390/jpm10040146
157.
Fan Q Zhu H Zhao J Zhuang L Zhang H Xie H. ESC Heart Fail. risk factors for myocardial injury in patients with coronavirus disease 2019 in China. ESC Heart Fail. (2020 ).
Not in our library10.1002/ehf2.13022
158.
Bonow RO Fonarow GC O'Gara PT Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. (2020 ) 5:751–3.
Not in our library10.1001/jamacardio.2020.1105
159.
Wan Y Shang J Graham R Baric RS Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. (2020 ) 94:e00127-20.
Not in our library10.1128/jvi.00127-20
160.
Yehualashet AS Belachew TF. ACEIs and ARBs and their correlation with COVID-19: a review. Infect Drug Resist. (2020 ) 13:3217–24.
Not in our library10.2147/idr.s264882
161.
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension · 2020
No notice
162.
Li J Wang X Chen J Zhang H Deng A Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. (2020 ) 5:825–30.
Not in our library10.1001/jamacardio.2020.1624
163.
Oudit GY Kassiri Z Jiang C Liu PP Poutanen SM Penninger JM. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. (2009 ) 39:618–25.
Not in our library10.1111/j.1365-2362.2009.02153.x
164.
Semenov AG Tamm NN Seferian KR Postnikov AB Karpova NS Serebryanaya DV. Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases. Clin Chem. (2010 ) 56:1166–76.
Not in our library10.1373/clinchem.2010.143883
165.
Goulter AB Goddard MJ Allen JC Clark KL. ACE2 gene expression is up-regulated in the human failing heart. BMC Med. (2004 ) 2:19.
Not in our library10.1186/1741-7015-2-19
166.
Driggin E Madhavan MV Bikdeli B Chuich T Laracy J Biondi-Zoccai G. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. (2020 ) 75:2352–71.
Not in our library10.1016/j.jacc.2020.03.031
167.
Zidar DA Al-Kindi SG Liu Y Krieger NI Perzynski AT Osnard M. Association of lymphopenia with risk of mortality among adults in the us general population. JAMA Netw Open. (2019 ) 2:e1916526.
Not in our library10.1001/jamanetworkopen.2019.16526
168.
Tall AR Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. (2015 ) 15:104–16.
Not in our library10.1038/nri3793
169.
Cheng Y Luo R Wang K Zhang M Wang Z Dong L. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. (2020 ) 97:829–38.
Not in our library10.1016/j.kint.2020.03.005
170.
Pan XW Xu D Zhang H Zhou W Wang LH Cui XG. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. Intensive Care Med. (2020 ) 46:1114–6.
Not in our library10.1007/s00134-020-06026-1
171.
Acute kidney injury in SARS-CoV-2 infected patients · 2020
No notice
172.
Richardson S Hirsch JS Narasimhan M Crawford JM McGinn T Davidson KW. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. (2020 ) 323:2052–9.
Not in our library10.1001/jama.2020.6775
173.
Prasad N Agrawal SK On behalf of COVID-19 Working Group of Indian Society of Nephrology COVID 19 and acute kidney injury. Indian J Nephrol. (2020 ) 30:161–5.
Not in our library10.4103/ijn.ijn_120_20
174.
Fisher M Neugarten J Bellin E Yunes M Stahl L Johns TS. AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol. (2020 ) 31:2145–57.
Not in our library10.1681/asn.2020040509
175.
Acute kidney injury (2020 ). Available online at: http://www.nephjc.com/news/covidaki (accessed November 20, 2020).
Not in our library
176.
Su H Yang M Wan C Yi LX Tang F Zhu HY. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. (2020 ) 98:219–27.
Not in our library10.1016/j.kint.2020.04.003
177.
Tian J Yuan X Xiao J Zhong Q Yang C Liu B. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. (2020 ) 21:893–903.
Not in our library10.1016/s1470-2045(20)30309-0
178.
Gupta S Hayek SS Wang W Chan L Mathews KS Melamed ML. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. (2020 ) 15:e203596.
Not in our library10.1001/jamainternmed.2020.3596
179.
Pei G Zhang Z Peng J Liu L Zhang C Yu C. renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. (2020 ) 31:1157–65.
Not in our library10.1681/asn.2020030276
180.
Stewart DJ Hartley JC Johnson M Marks SD du Pré P Stojanovic J. Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health. (2020 ) 4:e28–9.
Not in our library10.1016/s2352-4642(20)30178-4
181.
Ronco C Reis T Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. (2020 ) 8:738–42.
Not in our library10.1016/s2213-2600(20)30229-0
182.
Guan WJ Zhong NS Clinical characteristics of Covid-19 in China. Reply. N Engl J Med. (2020 ) 382:1861–2.
Not in our library10.1056/nejmc2005203
183.
Martinez-Rojas MA Vega-Vega O Bobadilla NA. Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol. (2020 ) 318:F1454–62.
Not in our library10.1152/ajprenal.00160.2020
184.
Braun F Lütgehetmann M Pfefferle S Wong MN Carsten A Lindenmeyer MT. SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet. (2020 ) 396:597–8.
Not in our library10.1016/s0140-6736(20)31759-1
185.
Vijayan A Humphreys BD SARS-CoV-2 in the kidney: bystander or culprit? Nat Rev Nephrol. (2020 ) 16:703–4.
Not in our library10.1038/s41581-020-00354-7
186.
Suryawanshi H Morozov P Muthukumar T tenOever BR Yamaji M Williams Z Cell-type-specific expression of renin-angiotensin-system components in the human body and its relevance to SARS-CoV-2 infection. bioRxiv. (2020 ).
Not in our library10.1101/2020.04.11.034603
187.
Li Z Wu M Guo J Caution on kidney dysfunctions of 2019-nCoV patients 2020. medRxiv. (2020 ).
Not in our library10.1101/2020.02.08.20021212
188.
Ronco C Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nat Rev Nephrol. (2020 ) 16:308–10.
Not in our library10.1038/s41581-020-0284-7
189.
Luo S Zhang X Xu H. Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19). Clin Gastroenterol Hepatol. (2020 ) 18:1636–7.
Not in our library10.1016/j.cgh.2020.03.043
190.
Deng Y Liu W Liu K Fang YY Shang J Zhou L. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J. (2020 ) 133:1261–7.
Not in our library10.1097/cm9.0000000000000824
191.
Pan L Mu M Yang P Sun Y Wang R Yan J. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. (2020 ) 115:766–73.
Not in our library10.14309/ajg.0000000000000620
192.
Lu X Zhang L Du H Zhang J Li YY Qu J SARS-CoV-2 infection in children. N Engl J Med. (2020 ) 382:1663–5.
Not in our library10.1056/nejmc2005073
193.
Shi H Han X Jiang N Cao Y Alwalid O Gu J. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. (2020 ) 20:425–34.
Not in our library10.1016/s1473-3099(20)30086-4
194.
Xiao F Tang M Zheng X Liu Y Li X Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. (2020 ) 158:1831–3.e3.
Not in our library10.1053/j.gastro.2020.02.055
195.
Easom N Moss P Barlow G Samson A Taynton T Adams K. 68 Consecutive patients assessed for COVID19 infection; experience from a UK regional infectious disease unit. Influenza Other Respir Viruses. (2020 ) 14:374–9.
Not in our library10.1111/irv.12739
196.
Xu XW Wu XX Jiang XG Xu KJ Ying LJ Ma CL Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. (2020 ) 368:m606
Not in our library10.1136/bmj.m606
197.
Chu J Yang N Wei Y Yue H Zhang F Zhao J. Clinical Characteristics of 54 medical staff with COVID-19: a retrospective study in a single center in Wuhan, China. J Med Virol. (2020 ) 92:807–13.
Not in our library10.1002/jmv.25793
198.
Cheung KS Hung IFN Chan PPY Lung KC Tso E Liu R. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology. (2020 ) 159:81–59.
Not in our library10.1053/j.gastro.2020.03.065
199.
Kopel J Perisetti A Gajendran M Boregowda U Goyal H. Clinical insights into the gastrointestinal manifestations of COVID-19. Dig Dis Sci. (2020 ) 65:1932–9.
Not in our library10.1007/s10620-020-06362-8
200.
Galanopoulos M Gkeros F Doukatas A Karianakis G Pontas C Tsoukalas N. COVID-19 pandemic: pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. (2020 ) 26:4579–88.
Not in our library10.3748/wjg.v26.i31.4579
201.
Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges · 2020
Not checked
202.
Jin X Lian JS Hu JH Gao J Zheng L Zhang YM. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. (2020 ) 69:1002–9.
Not in our library10.1136/gutjnl-2020-320926
203.
Smyk W Janik MK Portincasa P Milkiewicz P Lammert F Krawczyk M. COVID-19: focus on the lungs but do not forget the gastrointestinal tract. Eur J Clin Invest. (2020 ) 14:e13276.
Not in our library10.1111/eci.13276
204.
Xu Y Li X Zhu B Liang H Fang C Gong Y. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. (2020 ) 26:502–5.
Not in our library10.1038/s41591-020-0817-4
205.
Liu Q Wang R Qu G Macroscopic autopsy findings in a patient with COVID-19. J Forensic Med. (2020 ) 36:1–3.
Not in our library
206.
Wölfel R Corman VM Guggemos W Seilmaier M Zange S Müller MA. Virological assessment of hospitalized patients with COVID-2019. Nature. (2020 ) 581:465–9.
Not in our library10.1038/s41586-020-2196-x
207.
Liang W Feng Z Rao S Xiao C Xue X Lin Z. Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus. Gut. (2020 ) 69:1141–3.
Not in our library10.1136/gutjnl-2020-320832
208.
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes · 2020
No notice
209.
Guo AX Cui JJ OuYang QY He L Guo CX Yin JY The clinical characteristics and mortal causes analysis of COVID-19 death patients. bioRxiv. (2020 ).
Not in our library10.1101/2020.04.12.20062380
210.
Zhang H Kang Z Gong H Xu D Wang J Li Z Cui X The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. (2020 ).
Not in our library10.1101/2020.01.30.927806
211.
Zhang Y Zheng L Liu L Zhao M Xiao J Zhao Q. Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China. Liver Int. (2020 ) 40:2095–103.
Not in our library10.1111/liv.14455
212.
Bloom PP Meyerowitz EA Reinus Z Daidone M Gustafson J Kim AY Liver biochemistries in hospitalized patients with COVID-19. Hepatology. (2020 ).. [Epub ahead of print].
Not in our library10.1002/hep.31326
213.
Agarwal A Chen A Ravindran N To C Thuluvath PJ. Gastrointestinal and liver manifestations of COVID-19. J Clin Exp Hepatol. (2020 ) 10:263–5.
Not in our library10.1016/j.jceh.2020.03.001
214.
Zhang Y Xiao M Zhang S Xia P Cao W Jiang W. Coagulopathy and antiphospholipid antibodies in patients with covid-19. N Engl J Med. (2020 ) 382:e38.
Not in our library10.1056/nejmc2007575
215.
Tang N Li D Wang X Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. (2020 ) 18:844–7.
Not in our library10.1111/jth.14768
216.
Chai X Hu L Zhang Y Han W Lu Z Ke A Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. (2020 ).
Not in our library10.1101/2020.02.03.931766
217.
Sanz Segura P Arguedas Lázaro Y Mostacero Tapia S Cabrera Chaves T Sebastián Domingo JJ. Involvement of the digestive system in covid-19. A review. Gastroenterol Hepatol. (2020 ) 43:464–71.
Not in our library10.1016/j.gastrohep.2020.06.004
218.
Metawea MI Yousif WI Moheb I. COVID 19 and liver: an A-Z literature review. Dig Liver Dis. (2020 ).. [Epub ahead of print].
Not in our library10.1016/j.dld.2020.09.010
219.
Parohan M. Yaghoubi S Seraj A. Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies. Hepatol Res. (2020 ) 50:924–35.
Not in our library10.1111/hepr.13510
220.
Lei F Liu YM Zhou F Qin JJ Zhang P Zhu L. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology. (2020 ) 72:389–98.
Not in our library10.1002/hep.31301
221.
Ji D Qin E Xu J Zhang D Cheng G Wang Y. Non-alcoholic fatty liver diseases in patients with COVID-19: a retrospective study. J Hepatol. (2020 ) 73:451–3.
Not in our library10.1016/j.jhep.2020.03.044
222.
Sonzogni A Previtali G Seghezzi M Alessio MG Gianatti A Licini L Liver and COVID 19 infection: a very preliminary lesson learnt from histological post-mortem findings in 48 patients. Liver Int. (2020 ) 40:2110–6.
Not in our library10.20944/preprints202004.0438.v1
223.
Zhou L Niu Z Jiang X Zhang Z Zheng Y Wang Z. Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2, TMPRSS2 and furin proteases. bioRxiv. (2020 ).. [Epub ahead of print].33134888
Not in our library10.1101/2020.04.06.028522
224.
Barth RE De Regt MJA. Persistence of viral RNA in stool samples from patients recovering from covid-19. BMJ. (2020 ) 369:m1724.
Not in our library10.1136/bmj.m1724
225.
Li J Fan J. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. (2020 ) 8:13–7.
Not in our library10.14218/jcth.2020.00019
226.
Bhayana R Som A Li MD Carey DE Anderson MA Blake MA. Abdominal imaging findings in COVID-19: preliminary observations. Radiology. (2020 ) 297:201908.
Not in our library10.1148/radiol.2020201908
227.
COVID-19 with acute cholecystitis: a case report · 2020
Not checked
228.
Fu L Fei J Xu S Xiang H-X Xiang [Y Tan Z-X Acute liver injury and its association with death risk of patients with COVID-19: a hospital-based prospective case-cohort study. medrxiv. (2020 ).. [Epub ahead of print].
Not in our library10.1101/2020.04.02.20050997
229.
Wang F Wang H Fan J Zhang Y Wang H Zhao Q. Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia. Gastroenterology. (2020 ) 159:367–70.
Not in our library10.1053/j.gastro.2020.03.055
230.
Kataria S Sharif A Ur Rehman A Ahmed Z Hanan A. COVID-19 induced acute pancreatitis: a case report and literature review. Cureus. (2020 ) 12:e9169.
Not in our library10.7759/cureus.9169
231.
Hadi A Werge M Kristiansen KT Pedersen UG Karstensen JG Novovic S. Coronavirus disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members. Pancreatology. (2020 ) 20:665–7.
Not in our library10.1016/j.pan.2020.04.021
232.
Liu F Long X Zhang B Zhang W Chen X Zhang Z. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin Gastroenterol Hepatol. (2020 ) 18:2128–30.e2.
Not in our library10.1016/j.cgh.2020.04.040
233.
Verma K Amitabh Prasad DN Kumar B Kohli E. Brain and COVID-19 crosstalk: pathophysiological and psychological manifestations. ACS Chem Neurosci. (2020 ) 11:3194–203.
Not in our library10.1021/acschemneuro.0c00446
234.
Soltani Zangbar H Gorji A Ghadiri T. A review on the neurological manifestations of covid-19 infection: a mechanistic view. Mol Neurobiol. (2020 ) 26:1–14.
Not in our library10.1007/s12035-020-02149-0
235.
Josephson SA Kamel H. Neurology and COVID-19. JAMA. (2020 ) 324:1139–40.
Not in our library10.1001/jama.2020.14254
236.
Orrù G Conversano C Malloggi E Francesconi F Ciacchini R Gemignani A. Neurological complications of COVID-19 and possible neuroinvasion pathways: a systematic review. Int J Environ Res Public Health. (2020 ) 17:e6688.
Not in our library10.3390/ijerph17186688
237.
Mao XY Jin WL. The COVID-19 pandemic: consideration for brain infection. Neuroscience. (2020 ) 437:130–1.
Not in our library10.1016/j.neuroscience.2020.04.04
238.
Avula A Nalleballe K Narula N Sapozhnikov S Dandu V Toom S. COVID-19 presenting as stroke. Brain Behav Immun. (2020 ) 87:115–9.
Not in our library10.1016/j.bbi.2020.04.077
239.
Morassi M Bagatto D Cobelli M D'Agostini S Gigli GL Bnà C. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. (2020 ) 267:2185–92.
Not in our library10.1007/s00415-020-09885-2
240.
Beyrouti R Adams ME Benjamin L Cohen H Farmer SF Goh YY. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. (2020 ) 91:889–91.
Not in our library10.1136/jnnp-2020-323586
241.
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 · 2020
Not checked
242.
Duong L Xu P Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles, early april 2020. Brain Behav Immun. (2020 ) 87:33.
Not in our library10.1016/j.bbi.2020.04.024
243.
Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology · 2020
No notice
244.
Zoghi A Ramezani M Roozbeh M Darazam IA Sahraian MA. A case of possible atypical demyelinating event of the central nervous system following COVID-19. Mult Scler Relat Disord. (2020 ) 44:102324.
Not in our library10.1016/j.msard.2020.102324
245.
Virani A Rabold E Hanson T Haag A Elrufay R Cheema T. Guillain-barré syndrome associated with SARS-CoV-2 infection. IDCases. (2020 ) 20:e00771.
Not in our library10.1016/j.idcr.2020.e00771
246.
Toscano G Palmerini F Ravaglia S Ruiz L Invernizzi P Cuzzoni MG. Guillain–barré syndrome associated with SARS-CoV-2. N Engl J Med. (2020 ) 382:2574–6.
Not in our library10.1056/nejmc2009191
247.
Alberti P Beretta S Piatti M Karantzoulis A Piatti ML Santoro P Guillain–barré syndrome associated with SARS-CoV-2. Neurol Neuroimmunol. (2020 ) 7:e741
Not in our library10.1212/nxi.0000000000000741
248.
Paybast S Gorji R Mavandadi S. Guillain-barré syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature. Neurologist. (2020 ) 25:101–3.
Not in our library10.1097/nrl.0000000000000291
249.
Dinkin M Gao V Kahan J Bobker S Simonetto M Wechsler P COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. (2020 ) 95:221–3.
Not in our library10.1212/wnl.0000000000009700
250.
Gutiérrez-Ortiz C Méndez-Guerrero A Rodrigo-Rey S San Pedro-Murillo E Bermejo-Guerrero L Gordo-Mañas R Miller fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. (2020 ) 95:e601–5.
Not in our library10.1212/wnl.0000000000009619
251.
Lantos JE Strauss SB Lin E. COVID-19-associated miller fisher syndrome: MRI findings. AJNR Am J Neuroradiol. (2020 ) 41:1184–6.
Not in our library10.3174/ajnr.a6609
252.
Poyiadji N Shahin G Noujaim D Stone M Patel S Griffith B. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. (2020 ) 296:201187.
Not in our library10.1148/radiol.2020201187
253.
Kandemirli SG Dogan L Sarikaya ZT Kara S Akinci C Kaya D. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. (2020 ) 297:E232–5.
Not in our library10.1148/radiol.2020201697
254.
Zanin L Saraceno G Panciani PP Renisi G Signorini L Migliorati K. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir. (2020 ) 162:1491–4.
Not in our library10.1007/s00701-020-04374-x
255.
Helms J Kremer S Merdji H Clere-Jehl R Schenck M Kummerlen C Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. (2020 ) 382:2268–70.
Not in our library10.1056/nejmc2008597
256.
COVID-19: ICU delirium management during SARS-CoV-2 pandemic · 2020
No notice
257.
Li K Wohlford-Lenane C Perlman S Zhao J Jewell AK Reznikov LR. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis. (2016 ) 213:712–22.
Not in our library10.1093/infdis/jiv499
258.
Mannan Baig A Khaleeq A Ali U Syeda H Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. (2020 ) 11:995–8.
Not in our library10.1021/acschemneuro.0c00122
259.
Hoenig LJ. Update on the cutaneous manifestations of COVID-19. Clin Dermatol. (2020 ) 38:507.
Not in our library10.1016/j.clindermatol.2020.04.016
260.
Wiwanitkit V Cutaneous manifestations of COVID-19. Arch Dermatol Res. (2020 ) 1
Not in our library10.1007/s00403-020-02144-4
261.
Drenovska K Schmidt E Vassileva S. Covid-19 pandemic and the skin. Int J Dermatol. (2020 ).. [Epub ahead of print].
Not in our library10.1111/ijd.15189
262.
Nieto-Benito LM Hernández de la Torre-Ruiz E Balaguer-Franch I Rosell-Díaz ÁM Mateos-Mayo A Herrero-Sanchez A. Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature. Australas J Dermatol. (2020 ).. [Epub ahead of print].
Not in our library10.1111/ajd.13442
263.
Chaabane I Loukil M Amri R Badri I Baha H Lajmi M. Cutaneous manifestations of COVID-19: report of three cases. Arch Dermatol Res. (2020 ) 1–4.
Not in our library10.1007/s00403-020-02112-y
264.
Nasiri S Dadkhahfar S Abasifar H Mortazavi N Gheisari M Urticarial vasculitis in a COVID-19 recovered patient. Int J Dermatol. (2020 ).. [Epub ahead of print].
Not in our library10.1111/ijd.15112
265.
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. (2020 ) 34:e212–3.
Not in our library10.1111/jdv.16387
266.
Joob B Wiwanitkit V. COVID-19 can present with a rash and be mistaken for Dengue. J Am Acad Dermatol. (2020 ) 82:e177.
Not in our library10.1016/j.jaad.2020.03.036
267.
Lu S Lin J Zhang Z Xiao L Jiang Z Chen J. Alert for non-respiratory symptoms of coronavirus disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol. (2020 ).. [Epub ahead of print].
Not in our library10.1002/jmv.25776
268.
Zhang JJ Dong X Cao YY Yuan YD Yang YB Yan YQ. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. (2020 ) 75:1730–41.
Not in our library10.1111/all.14238
269.
Dastoli S Bennardo L Patruno C Nisticò SP Are erythema multiforme and urticaria related to a better outcome of COVID-19? Dermatol Ther. (2020 ) 24:e13681
Not in our library10.1111/dth.13681
270.
Algaadi SA. Urticaria and COVID-19: a review. Dermatol Ther. (2020 ) e14290.
Not in our library10.1111/dth.14290
271.
Galván Casas C Català A Carretero Hernández G Rodríguez-Jiménez P Fernández-Nieto D Rodríguez-Villa Lario A. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. (2020 ) 183:71–7.
Not in our library10.1111/bjd.19163
272.
Manalo IF Smith MK Cheeley J Jacobs R A dermatologic manifestation of COVID-19: transient livedo reticularis. J Am Acad Dermatol. (2020 ) 83:700
Not in our library10.1016/j.jaad.2020.04.018
273.
Magro C Mulvey JJ Berlin D Nuovo G Salvatore S Harp J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. (2020 ) 220:1–13.
Not in our library10.1016/j.trsl.2020.04.007
274.
Marzano AV Cassano N Genovese G Moltrasio C Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. (2020 ) 183:431–42.
Not in our library10.1111/bjd.19264
275.
Hedou M Carsuzaa F Chary E Hainaut E Cazenave-Roblot F Masson Regnault M. Comment on 'cutaneous manifestations in COVID-19: a first perspective' by Recalcati S. J Eur Acad Dermatol Venereol. (2020 ) 34:e299–300.
Not in our library10.1111/jdv.16519
276.
Similarities in Cutaneous Histopathological Patterns between COVID-19-positive and COVID-19 High-risk Patients with Skin Dermatosis · 2020
Not checked
277.
Mazzotta F Troccoli T Bonifazi E Acute acro-ischemia in the child at the time of COVID-19. Eur J Pediat Dermatol. (2020 ) 30:71–4.
Not in our library10.26326/2281-9649.30
278.
Duramaz BB Yozgat CY Yozgat Y Turel O. Appearance of skin rash in pediatric patients with COVID-19: three case presentations. Dermatol Ther. (2020 ) 33:e13594.
Not in our library10.1111/dth.13594
279.
Catalá Gonzalo A Galván Casas C. COVID-19 and the skin. Actas Dermosifiliogr. (2020 ) 111:447–9.
Not in our library10.1016/j.ad.2020.04.007
280.
Cordoro KM Reynolds SD Wattier R McCalmont TH. Clustered cases of acral perniosis: clinical features, histopathology and relationship to COVID-19. Pediatr Dermatol. (2020 ) 37:419–23.
Not in our library10.1111/pde.14227
281.
Locatelli AG Robustelli Test E Vezzoli P Carugno A Moggio E Consonni L. Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient. J Eur Acad Dermatol Venereol. (2020 ) 34:e365–8.
Not in our library10.1111/jdv.16617
282.
Kolivras A Dehavay F Delplace D Feoli F Meiers I Milone L. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathological findings. JAAD Case Rep. (2020 ) 6:489–92.
Not in our library10.1016/j.jdcr.2020.04.011
283.
Saenz Aguirre A De la Torre Gomar FJ Rosés-Gibert P Gimeno Castillo J Martinez de Lagrán Alvarez de Arcaya Z Gonzalez-Perez R. Novel outbreak of acral lesions in times of COVID-19: a description of 74 cases from a tertiary University hospital in Spain. Clin Exp Dermatol. (2020 ) 45:1065–7.
Not in our library10.1111/ced.14294
284.
Radzikowska U Ding M Tan G Zhakparov D Peng Y Wawrzyniak P. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. (2020 ) 75:2829–45.
Not in our library10.1111/all.14429
285.
ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients · 2021
No notice
286.
The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS‐CoV‐2 infection · 2020
No notice
287.
Zhang J Wu Y Wang R Lu K Tu M Guo H Bioinformatic analysis reveals that the reproductive system is potentially at risk from SARS-CoV-2. Preprints. (2020 ).
Not in our library10.20944/preprints202002.0307.v1
288.
Zupin L Pascolo L Zito G Ricci G Crovella S. SARS-CoV-2 and the next generations: which impact on reproductive tissues? J Assist Reprod Genet. (2020 ) 37:2399–403.
Not in our library10.1007/s10815-020-01917-0
289.
Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019 · 2020
No notice
290.
Bian XW The COVID-19 Pathology Team. Autopsy of COVID-19 patients in China. Natl Sci Rev. (2020 ) nwaa123
Not in our library10.1093/nsr/nwaa123
291.
Pan F Xiao X Guo J Song Y Li H Patel DP. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril. (2020 ) 113:1135–9.
Not in our library10.1016/j.fertnstert.2020.04.024
292.
Song C Wang Y Li W Hu B Chen G Xia P. Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients†. Biol Reprod. (2020 ) 103:4–6.
Not in our library10.1093/biolre/ioaa050
293.
Yang M Chen S Huang B Zhong JM Su H Chen YJ. Pathological findings in the testes of COVID-19 patients: clinical implications. Eur Urol Focus. (2020 ) 6:1124–9.
Not in our library10.1016/j.euf.2020.05.009
294.
Chen H Guo J Wang C Luo F Yu X Zhang W. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. (2020 ) 395:809–15.
Not in our library10.1016/s0140-6736(20)30360-3
295.
Brandt JS Hill J Reddy A Schuster M Patrick HS Rosen T. Epidemiology of COVID-19 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am J Obstet Gynecol. (2020 ).. [Epub ahead of print].
Not in our library10.1016/j.ajog.2020.09.043
296.
Liu Y Chen H Tang K Guo Y Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. (2020 ).. [Epub ahead of print].
Not in our library10.1016/j.jinf.2020.02.028
297.
Di Mascio D Khalil A Saccone G Rizzo G Buca D Liberati M. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. (2020 ) 2:100107.
Not in our library10.1016/j.ajogmf.2020.100107
298.
Abbas AM Ahmed OA Shaltout AS. COVID-19 and maternal pre-eclampsia: a synopsis. Scand J Immunol. (2020 ) 92:e12918.
Not in our library10.1111/sji.12918
299.
Dap M Morel O Proteinuria in covid-19 pregnant women: preeclampsia or severe infection? Eur J Obstet Gynecol Reprod Biol. (2020 ) 252:612
Not in our library10.1016/j.ejogrb.2020.07.005
300.
Di Mascio D Sen C Saccone G Galindo A Grünebaum A Yoshimatsu J. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19. J Perinat Med. (2020 ) 48:950–8.
Not in our library10.1515/jpm-2020-0355
301.
Wastnedge EA Reynolds RM van Boeckel SR Stock SJ Denison F Maybin JA. Pregnancy and COVID-19. Physiol Rev. (2020 ).. [Epub ahead of print].
Not in our library10.1152/physrev.00024.200
302.
Rasmussen SA Smulian JC Lednicky JA Wen TS Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. (2020 ) 222:415–26.
Not in our library10.1016/j.ajog.2020.02.017
303.
Alwardi TH Ramdas V Al Yahmadi M Al Aisari S Bhandari S Saif Al Hashami H. Is vertical transmission of SARS-CoV-2 infection possible in preterm triplet pregnancy? a case series. Pediatr Infect Dis J. (2020 ).. [Epub ahead of print].
Not in our library10.1097/inf.0000000000002926
304.
Baud D Nielsen-Saines K Qi X Musso D Pomar L Favre G Authors' reply. Lancet Infect Dis. (2020 ) 20:775–6.
Not in our library10.1016/s1473-3099(20)30255-3
305.
Kotlyar AM Grechukhina O Chen A Popkhadze S Grimshaw A Tal O Vertical transmission of COVID-19: a systematic review and meta-analysis. Am J Obstet Gynecol. (2020 ) 31:e00087320
Not in our library10.1016/j.ajog.2020.07.049
306.
Patanè L Morotti D Giunta MR Sigismondi C Piccoli MG Frigerio L. Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019-positive mothers and neonates at birth. Am J Obstet Gynecol MFM. (2020 ) 2:100145.
Not in our library10.1016/j.ajogmf.2020.100145
307.
Whittaker E Bamford A Kenny J Kaforou M Jones CE Shah P. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. (2020 ) 324:259–69.
Not in our library10.1001/jama.2020.10369
308.
Placental Pathology in Covid-19 Positive Mothers: Preliminary Findings · 2020
No notice
309.
The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study · 2020
No notice
310.
Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? · 2020
No notice
311.
Gengler C Dubruc E Favre G Greub G de Leval L Baud D. SARS-CoV-2 ACE-Receptor detection in the placenta throughout pregnancy. Clin Microbiol Infect. (2020 ).. [Epub ahead of print].
Not in our library10.1016/j.cmi.2020.09.049
312.
Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester · 2020
Not checked
313.
Jaimes JA Millet JK Whittaker GR. Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site. iScience. (2020 ) 23:101212.
Not in our library10.1016/j.isci.2020.101212
314.
Ashary N Bhide A Chakraborty P Colaco S Mishra A Chhabria K. Single-cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2. Front Cell Dev Biol. (2020 ) 8:783.
Not in our library10.3389/fcell.2020.00783
315.
Pal R Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. (2020 ) 43:1027–31.
Not in our library10.1007/s40618-020-01276-8
316.
Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study · 2020
Not checked
317.
Campos-Barrera E Alvarez-Cisneros T Davalos-Fuentes M. Subacute Thyroiditis Associated with COVID-19. Case Rep Endocrinol. (2020 ) 2020:8891539.
Not in our library10.1155/2020/8891539
318.
Muller I Cannavaro D Dazzi D Covelli D Mantovani G Muscatello A. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. (2020 ) 8:739–41.
Not in our library10.1016/s2213-8587(20)30266-7
319.
Brancatella A Ricci D Viola N Sgrò D Santini F Latrofa F Subacute thyroiditis after SARS-COV-2 infection. J Clin Endocrinol Metab. (2020 ) 105:dgaa276
Not in our library10.1210/clinem/dgaa276
320.
Ippolito S Dentali F Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. (2020 ) 43:1171–2.
Not in our library10.1007/s40618-020-01312-7
321.
Ruggeri RM Campennì A Siracusa M Frazzetto G Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones. (2020 ) 16:1–3.
Not in our library10.1007/s42000-020-00230-w
322.
Mattar SAM Koh SJQ Rama Chandran S Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. (2020 ) 13:e237336.
Not in our library10.1136/bcr-2020-237336
323.
Brancatella A Ricci D Cappellani D Viola N Sgrò D Santini F. Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? Insights from a case series. J Clin Endocrinol Metab. (2020 ) 105:dgaa537.
Not in our library10.1210/clinem/dgaa537
324.
Kalkan EA Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Invest. (2020 ) 43:1173–4.
Not in our library10.1007/s40618-020-01316-3
325.
Chen T Wu D Chen H Yan W Yang D Chen G. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. (2020 ) 368:m1091.
Not in our library10.1136/bmj.m1091
326.
Chen M Zhou W Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid. (2020 ).. [Epub ahead of print].
Not in our library10.1089/thy.2020.0363
327.
Gorini F Bianchi F Iervasi G. COVID-19 and thyroid: progress and prospects. Int J Environ Res Public Health. (2020 ) 17:E6630.
Not in our library10.3390/ijerph17186630
328.
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues · 2020
No notice
329.
Santos RAS Sampaio WO Alzamora AC Motta-Santos D Alenina N Bader M. The ACE2/Angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev. (2018 ) 98:505–53.
Not in our library10.1152/physrev.00023.2016
330.
Batlle D Wysocki J Satchell K. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci. (2020 ) 134:543–5.
Not in our library10.1042/cs20200163
331.
Li W Moore MJ Vasilieva N Sui J Wong SK Berne MA. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. (2003 ) 426:450–4.
Not in our library10.1038/nature02145
332.
Monteil V Kwon H Prado P Hagelkrüys A Wimmer RA Stahl M. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble Human ACE2. Cell. (2020 ) 181:905–13.e7.
Not in our library10.1016/j.cell.2020.04.004
333.
Roshanravan N Ghaffari S Hedayati M. Angiotensin converting enzyme-2 as therapeutic target in COVID-19. Diabetes Metab Syndr. (2020 ) 14:637–9.
Not in our library10.1016/j.dsx.2020.05.022
334.
COVID-19: immunopathogenesis and Immunotherapeutics · 2020
No notice
335.
Lippi G Mario Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. (2020 ) 58:1131–4.
Not in our library10.1515/cclm-2020-0198
336.
Ni L Ye F Cheng ML Feng Y Deng YQ Zhao H. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. (2020 ) 52:971–7.e3.
Not in our library10.1016/j.immuni.2020.04.023
337.
Functional exhaustion of antiviral lymphocytes in COVID-19 patients · 2020
No notice
338.
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19 · 2020
No notice
339.
Qin C Zhou L Hu Z Zhang S Yang S Tao Y. Dysregulation of immune response in patients with coronavirus (2019 (COVID-19) in Wuhan, China. Clin Infect Dis. (2020 ) 71:762–8.
Not in our library10.1093/cid/ciaa248
340.
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease · 2020
No notice
341.
Considerations for Postacute Rehabilitation for Survivors of COVID-19 · 2020
No notice

Cited by papers we hold 1

Skin Aging, Cellular Senescence and Natural Polyphenols · 2021
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.